We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

Tailoring Treatment for Triple-negative Breast Cancer

News   Apr 14, 2020 | Original story from University of Pennsylvania

 
Tailoring Treatment for Triple-negative Breast Cancer

Researchers from the University of Pennsylvania found that that the protein Elf5 in mammary tumors plays a role in the progression and spread of triple-negative breast cancer in an animal model. Cells with Elf5 are noted in green above. Credit: Snahlata Singh and Rumela Chakrabarti

 
 
Advertisement
 

RELATED ARTICLES

Study Reveals How SARS-CoV-2 Infects Heart Cells

News

A new study provides evidence that COVID-19 patients' heart damage is caused by the virus invading and replicating inside heart muscle cells, leading to cell death and interfering with heart muscle contraction.

READ MORE

Food Ingredient Sesaminol Alleviates Parkinson’s Symptoms in Mice

News

Researchers have discovered that the waste from sesame seed oil production has an abundance of a chemical called sesaminol, which has protective effects against Parkinson's disease.

READ MORE

Drug Designed To Treat Cancers Associated With Epstein–Barr Virus

News

Epstein-Barr virus (EBV) has infected more than 90% of the human population worldwide. EBV is known to play a key role in several cancers such as nasopharyngeal carcinoma. A research team has developed a novel drug that could become a next-generation treatment for cancers associated with EBV.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Biopharma Cancer Research Immunology & Microbiology

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE